No Picture
News Feed

Citius Pharmaceuticals, Inc. Provides First Half 2021 Business Update, Highlights Upcoming Milestones

– Phase 3 Mino-Lok® trial proceeding as planned following recommendation by independent Data Monitoring Committee (DMC), highlighting important safety and efficacy signals – – Mino-Lok® New Drug Application (NDA) submission planned for 2022 following anticipated […]

No Picture
Featured Interviews

Ryah Group, Inc (CSE: RYAH)

ABOUT: RYAH Group, Inc. (‘RYAH’) is a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry. Its robust artificial intelligence platform aggregates […]